The defeat of Philip Morris' 'California Uniform Tobacco Control Act'

American Journal of Public Health
H R MacdonaldS A Glantz

Abstract

This paper describes the strategies used by Philip Morris and other tobacco companies to promote a California initiative (Proposition 188) preempting local control of tobacco and those used by public health groups to defeat the initiative. Interviews with key informants were conducted, and the written record was reviewed. Tobacco companies nearly succeeded in passing Proposition 188 by presenting it as a pro-health measure that would prevent children from obtaining cigarettes and provide protection against secondhand smoke. Public health groups defeated it by highlighting tobacco industry backing. A private charitable foundation also played an innovative role by financing a non-partisan public education campaign. Public health forces must be alert to sophisticated efforts by the tobacco industry to enact preemptive state legislation by making it look like tobacco control legislation. The coalition structure that emerged in the "No on 188" campaign represents an effective model for future tobacco control activities. The new role of charitable foundations defined in the Proposition 188 campaign can be used in other public health issues.

References

Jan 1, 1992·Journal of Health Politics, Policy and Law·B E SamuelsS A Glantz
Sep 1, 1992·American Journal of Public Health·J L ForsterS Kelder
May 27, 1992·JAMA : the Journal of the American Medical Association·A A Skolnick
Oct 16, 1991·JAMA : the Journal of the American Medical Association·B Samuels, S A Glantz
Sep 26, 1990·JAMA : the Journal of the American Medical Association·F A StillmanH R Waranch
Sep 26, 1990·JAMA : the Journal of the American Medical Association·D G BalD Niemeyer
Oct 1, 1987·Circulation·S A Glantz
Jul 19, 1995·JAMA : the Journal of the American Medical Association·V L Crawford
Sep 1, 1995·American Journal of Public Health·M T CardadorS A Glantz
Feb 22, 1995·JAMA : the Journal of the American Medical Association·A A Skolnick
Mar 8, 1995·JAMA : the Journal of the American Medical Association·E ConliskM Eriksen
Oct 19, 1994·JAMA : the Journal of the American Medical Association·S MooreC E Douglas
Oct 19, 1994·JAMA : the Journal of the American Medical Association·S A Glantz, M E Begay
Oct 19, 1994·JAMA : the Journal of the American Medical Association·J A Califano
May 11, 1994·JAMA : the Journal of the American Medical Association·A A Skolnick
Jul 28, 1993·JAMA : the Journal of the American Medical Association·M P TraynorS A Glantz
Sep 1, 1993·American Journal of Public Health·M E BegayS A Glantz
Jun 28, 1993·Archives of Internal Medicine·T J WoodruffS A Glantz
Sep 18, 1996·JAMA : the Journal of the American Medical Association·S A Glantz
Sep 18, 1996·JAMA : the Journal of the American Medical Association·L H Pastor
Jan 1, 1996·Journal of Health Politics, Policy and Law·M P Traynor, S A Glantz

❮ Previous
Next ❯

Citations

Jun 2, 2001·Tobacco Control·M S Givel, S A Glantz
Jun 2, 2001·Tobacco Control·S MagzamenS A Glantz
Mar 15, 2002·Tobacco Control·C Mekemson, S A Glantz
Dec 22, 1999·Tobacco Control·L K Goldman, S A Glantz
Jan 20, 2009·American Journal of Public Health·Gregory J TungStanton A Glantz
Jan 31, 2002·American Journal of Public Health·Joanna V Dearlove, Stanton A Glantz
May 31, 2002·American Journal of Public Health·William J Bartosch, Gregory C Pope
Apr 7, 2007·American Journal of Public Health·DeKeely HartsfieldKaren L McKie
Jun 10, 1998·American Journal of Public Health·F Monardi, S A Glantz
Feb 24, 2001·American Journal of Public Health·S Magzamen, S A Glantz
Jan 1, 2008·Prevention and Control : the Official Journal of the World Heart Federation·Ernesto M SebriéStanton A Glantz
Oct 1, 2016·American Journal of Health Promotion : AJHP·Ricardo J WraySantosh Vijaykumar
Feb 21, 2018·Tobacco Control·Joanne D'SilvaNicole T Villaluz
Jan 22, 2021·American Journal of Public Health·Neiloy R Sircar, Stanton A Glantz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.